Skip to content
Let’s talk about advancements in R&D, trial designs, new compounds, regulatory affairs, patient engagement, and new forms of partnerships.

Details
Date:
11/08/2021
Start Time:
3:10 pm
End Time:
15:30

Maria Velkova

Managing Partner, Tabula Rasa Ventures

Maria Velkova is the Managing Partner of Tabula Rasa Ventures, an acceleration fund focused on the blind spots of the healthcare industry, starting with psychedelic therapeutics. She is a seasoned bio…

Joel Stanley

Chief Executive Officer, Founder, AJNA BioSciences

Joel Stanley – CEO and Co-Founder Ajna Holdings PBC, and former CEO and Chairman of the Board at Charlotte’s Web. Joel is the oldest of the seven Stanley Brothers, who are known for developing the int…

James Kuo, MD, MBA

Vice President of R&D, Silo Pharma

Dr. James (Jim) Kuo currently serves as Vice President of R&D at Silo Pharma. In addition, he is Managing Director of Athena Bioventures, Chairman of the board of ImmunoPrecise Antibodies and a board …

Dillan DiNardo

CEO, Mindstate Design Labs

Dillan DiNardo is founder and CEO at Mindstate Design Labs, a preclinical-stage biotechnology company developing the next generation of mental health therapeutics through the precision design of the p…

Olga Chernoloz, PhD

Chief Scientific Officer, Wake Network

With a Ph.D. in Neuroscience Olga has held a number of roles in clinical trial management, drug development, biotech, and pharmaceutics. As a trained neuropharmacologist and a registered pharmacist Dr…

Debra Borchardt

Co-founder and Executive Editor, Green Market Report

Debra Borchardt is the Co-founder and CEO of the financial news website Green Market Report. She is an award-winning journalist with a Masters Degree in Business Journalism from New York University. D…

Get Recordings Now!

Easily access the recordings for your favorite Wonderland sessions, allowing you to revisit the discussions and insights shared by our visionary speakers.

Buy Now